RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aceso Life Science Group Stock

Aceso Life Science Group ROE 2024

Aceso Life Science Group ROE

0

Ticker

474.HK

ISIN

KYG0070S1066

In 2024, Aceso Life Science Group's return on equity (ROE) was 0, a -100% increase from the -0.18 ROE in the previous year.

Aceso Life Science Group Aktienanalyse

What does Aceso Life Science Group do?

Aceso Life Science Group Ltd is a UK-based company specializing in the field of medical cannabis. The company was founded in 2016 when the founders recognized the growing demand for medical cannabis and decided to utilize their expertise in this area to establish a company focused on the development and marketing of cannabis products. Aceso's business model is based on various pillars. On one hand, the company offers product design and research and development in the field of medical cannabis products. Aceso also provides various services to help other companies and research institutions develop and bring their own commercial products to market. The company also has a strong presence in retail, where it offers a wide range of cannabinoid products. Aceso Life Science Group has various divisions that focus on the production of medical cannabis products. This includes the manufacturing of medical cannabinoids, which involves the preparation of cannabis oil and other products. Aceso also offers various types of medical cannabis, such as different THC and CBD-based products, and has also developed a special line of products targeting women. Aceso also has a strong presence in research and development, with a dedicated department focused on the development of new and improved cannabinoid products. Aceso's research department works closely with academic research institutions and other organizations to investigate and improve the efficacy and safety of medical cannabis and its derivatives. The products offered by Aceso primarily include medical oils, capsules, tinctures, and creams. These products contain a wide range of cannabinoids, such as CBD, THC, CBG, and CBN, which can be used to treat various conditions. Aceso has also developed a special series of products targeting women, including specific vaginal creams that can be used to treat pain and discomfort associated with the menstrual cycle and other conditions. Overall, Aceso Life Science Group Ltd has established itself as a leading company in the field of medical cannabis products. The company has developed a wide range of products and services aimed at providing its customers with a safe and effective way to treat various conditions. With a strong retail presence and a dedicated research department, Aceso has everything it needs to continue to play a pioneering role in the medical cannabis industry. Aceso Life Science Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Aceso Life Science Group's Return on Equity (ROE)

Aceso Life Science Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Aceso Life Science Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Aceso Life Science Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Aceso Life Science Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Aceso Life Science Group stock

What is the ROE (Return on Equity) of Aceso Life Science Group this year?

The ROE of Aceso Life Science Group this year is 0 undefined.

How has the Return on Equity (ROE) of Aceso Life Science Group developed compared to the previous year?

The ROE of Aceso Life Science Group has increased by -100% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Aceso Life Science Group?

A high ROE indicates that Aceso Life Science Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Aceso Life Science Group?

A low ROE can indicate that Aceso Life Science Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Aceso Life Science Group affect the company?

A change in ROE (Return on Equity) of Aceso Life Science Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Aceso Life Science Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Aceso Life Science Group?

Some factors that can influence Aceso Life Science Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Aceso Life Science Group pay?

Over the past 12 months, Aceso Life Science Group paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 42.38 %. For the coming 12 months, Aceso Life Science Group is expected to pay a dividend of 0 HKD.

What is the dividend yield of Aceso Life Science Group?

The current dividend yield of Aceso Life Science Group is 42.38 %.

When does Aceso Life Science Group pay dividends?

Aceso Life Science Group pays a quarterly dividend. This is distributed in the months of September, September, September, September.

How secure is the dividend of Aceso Life Science Group?

Aceso Life Science Group paid dividends every year for the past 0 years.

What is the dividend of Aceso Life Science Group?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aceso Life Science Group located?

Aceso Life Science Group is assigned to the 'Finance' sector.

Wann musste ich die Aktien von Aceso Life Science Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aceso Life Science Group from 9/2/2009 amounting to 0.012 HKD, you needed to have the stock in your portfolio before the ex-date on 8/14/2009.

When did Aceso Life Science Group pay the last dividend?

The last dividend was paid out on 9/2/2009.

What was the dividend of Aceso Life Science Group in the year 2023?

In the year 2023, Aceso Life Science Group distributed 0 HKD as dividends.

In which currency does Aceso Life Science Group pay out the dividend?

The dividends of Aceso Life Science Group are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aceso Life Science Group

Our stock analysis for Aceso Life Science Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aceso Life Science Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.